Hypertension, cerebrovascular impairment, and cognitive decline in aged AbetaPP/PS1 mice
Publication year
2017Source
Theranostics, 7, 5, (2017), pp. 1277-1289ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Anatomy
Medical Imaging
Journal title
Theranostics
Volume
vol. 7
Issue
iss. 5
Page start
p. 1277
Page end
p. 1289
Subject
Radboudumc 15: Urological cancers RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 1: Alzheimer`s disease DCMN: Donders Center for Medical Neuroscience; Anatomy Radboud University Medical Center; Medical Imaging - Radboud University Medical CenterAbstract
Cardiovascular risk factors, especially hypertension, are also major risk factors for Alzheimer's disease (AD). To elucidate the underlying vascular origin of neurodegenerative processes in AD, we investigated the relation between systolic blood pressure (SBP) cerebral blood flow (CBF) and vasoreactivity with brain structure and function in a 16-18 months old double transgenic AbetaPPswe/PS1dE9 (AbetaPP/PS1) mouse model for AD. These aging AbetaPP/PS1 mice showed an increased SBP linked to a declined regional CBF. Furthermore, using advanced MRI techniques, decline of functional and structural connectivity was revealed in the AD-like mice coupled to impaired cognition, increased locomotor activity, and anxiety-related behavior. Post mortem analyses demonstrated also increased neuroinflammation, and both decreased synaptogenesis and neurogenesis in the AbetaPP/PS1 mice. Additionally, deviant levels of fatty acids and sterols were present in the brain tissue of the AbetaPP/PS1 mice indicating maladapted brain fatty acid metabolism. Our findings suggest a link between increased SBP, decreased cerebral hemodynamics and connectivity in an AD mouse model during aging, leading to behavioral and cognitive impairments. As these results mirror the complex clinical symptomatology in the prodromal phase of AD, we suggest that this AD-like murine model could be used to investigate prevention and treatment strategies for early AD patients. Moreover, this study helps to develop more efficient therapies and diagnostics for this very early stage of AD.
This item appears in the following Collection(s)
- Academic publications [246625]
- Electronic publications [134175]
- Faculty of Medical Sciences [93367]
- Open Access publications [107698]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.